Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis
H Mushahid, SA Shah, SH Farhan, MH Shuja… - American Journal of …, 2024 - Springer
Aim The efficacy and safety of bivalirudin when used concurrently with glycoprotein IIb/IIIa
inhibitors (GPI) is uncertain. In this systematic review and meta-analysis, we aimed to …
inhibitors (GPI) is uncertain. In this systematic review and meta-analysis, we aimed to …
Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis
H Mushahid, SA Shah, SH Farhan… - American journal of … - pubmed.ncbi.nlm.nih.gov
Aim The efficacy and safety of bivalirudin when used concurrently with glycoprotein IIb/IIIa
inhibitors (GPI) is uncertain. In this systematic review and meta-analysis, we aimed to …
inhibitors (GPI) is uncertain. In this systematic review and meta-analysis, we aimed to …
Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis.
H Mushahid, SA Shah, SH Farhan… - American Journal of …, 2024 - europepmc.org
Aim The efficacy and safety of bivalirudin when used concurrently with glycoprotein IIb/IIIa
inhibitors (GPI) is uncertain. In this systematic review and meta-analysis, we aimed to …
inhibitors (GPI) is uncertain. In this systematic review and meta-analysis, we aimed to …